ATAI hero image

Atai gallery image 2

Atai gallery image 1

ATAI article header

ATAI logo

Atai gallery image 3

Atai image gallery

Invyxis will add proven medicinal chemistry and comprehensive biological evaluation capabilities to grow atai’s portfolio of new chemical entities (NCEs)

atai Life Sciences Launches Invyxis to Accelerate Discovery of Next-Generation Mental Health Treatments

Atai Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, with offices in New York, London and Berlin. Our vision is to heal mental health disorders so that everyone everywhere can live a more fulfilled life.

Discover brands image

Collect rewards image

Connect Accounts image

Create profile image

Create a profile

How it works - Create a Profile

Connect accounts

How it works - Connect Accounts

Discover brands

How it works - Discover Brands

Collect rewards

How it works - Collect Rewards

TiiCKER offers a completely personalized experience and first-ever way to view your stock portfolio, trade for free and invest in new companies while viewing your perks in one place! 

How it works

Homepage - How It Works

TiiCKER was created for fan-first, brand-first public companies—with exclusive perks served-up weekly to shareholders. Own stock? Connect your brokerage account to view more than 130 perks waiting for you right now!  

Start earning perks <span>today</span>

Join Now CTA

## Congratulations! You *qualify* for a TiiCKER *perk*

## Congratulations! You *may qualify* for a TiiCKER *perk*

TiiCKER Perk CTA

Atai Life Sciences N.V. operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD)